The Chemours Company (NYSE:CC) Holdings Lifted by Jade Capital Advisors LLC

Jade Capital Advisors LLC boosted its holdings in The Chemours Company (NYSE:CC) by 75.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 70,000 shares of the specialty chemicals company’s stock after acquiring an additional 30,000 shares during the quarter. Jade Capital Advisors LLC’s holdings in Chemours were worth $1,422,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. New Covenant Trust Company N.A. acquired a new stake in shares of Chemours during the 1st quarter valued at $29,000. Blue Trust Inc. lifted its holdings in shares of Chemours by 166.9% during the third quarter. Blue Trust Inc. now owns 1,169 shares of the specialty chemicals company’s stock valued at $26,000 after purchasing an additional 731 shares during the last quarter. Matrix Trust Co acquired a new position in shares of Chemours in the 3rd quarter valued at $25,000. North Star Investment Management Corp. increased its stake in Chemours by 1,510.0% in the 1st quarter. North Star Investment Management Corp. now owns 1,288 shares of the specialty chemicals company’s stock worth $34,000 after purchasing an additional 1,208 shares in the last quarter. Finally, Sunbelt Securities Inc. raised its holdings in Chemours by 1,969.7% during the 1st quarter. Sunbelt Securities Inc. now owns 1,366 shares of the specialty chemicals company’s stock worth $36,000 after buying an additional 1,300 shares during the period. 76.26% of the stock is owned by institutional investors and hedge funds.

Chemours Stock Performance

Shares of CC stock opened at $18.89 on Tuesday. The Chemours Company has a fifty-two week low of $15.10 and a fifty-two week high of $32.70. The stock’s 50-day moving average is $18.97 and its two-hundred day moving average is $22.83. The company has a debt-to-equity ratio of 5.45, a current ratio of 1.89 and a quick ratio of 1.01. The firm has a market cap of $2.81 billion, a P/E ratio of -8.71 and a beta of 1.74.

Chemours (NYSE:CC) last released its quarterly earnings data on Thursday, August 1st. The specialty chemicals company reported $0.38 EPS for the quarter, missing analysts’ consensus estimates of $0.57 by ($0.19). The firm had revenue of $1.54 billion during the quarter, compared to analyst estimates of $1.53 billion. Chemours had a return on equity of 33.21% and a net margin of 2.16%. The company’s quarterly revenue was down 6.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.10 EPS. Analysts predict that The Chemours Company will post 1.32 earnings per share for the current fiscal year.

Chemours Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 13th. Investors of record on Thursday, August 15th were issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 5.29%. The ex-dividend date was Thursday, August 15th. Chemours’s dividend payout ratio is presently -46.08%.

Wall Street Analysts Forecast Growth

Several research analysts have commented on CC shares. Royal Bank of Canada decreased their target price on shares of Chemours from $35.00 to $28.00 and set an “outperform” rating for the company in a report on Friday, October 11th. The Goldman Sachs Group lowered their price objective on shares of Chemours from $29.00 to $23.00 and set a “neutral” rating on the stock in a research report on Tuesday, September 3rd. UBS Group decreased their target price on Chemours from $30.00 to $28.00 and set a “buy” rating for the company in a research report on Tuesday, August 6th. BMO Capital Markets upped their price target on Chemours from $30.00 to $32.00 and gave the company an “outperform” rating in a research report on Monday, October 7th. Finally, Barclays reduced their price objective on Chemours from $22.00 to $21.00 and set an “equal weight” rating for the company in a research note on Wednesday, September 25th. Five investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Chemours has an average rating of “Hold” and a consensus target price of $25.38.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.